CAS 1300031-49-5 appears in our catalog under these names: I–BET151 (GSK1210151A), I-BET 151, I-BET151/ 99.03% (existing batch purity), I-BET151, 95%, I-BET151 98%. Offered by: GLPBio, TRC, TargetMol, Biosynth, Thermo Scientific (Acros). Available pack sizes: 5mg, 1mg, 2mg, 10mg, 25mg, 50mg, 100mg, 500mg.
I-BET151 is a member of the class of imidazoquinolines that is 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one substituted by (1R)-1-(pyridin-2-yl)ethyl, 3,5-dimethyl-1,2-oxazol-4-yl, and methoxy groups at positions 1, 7, and 8, respectively. It is a pan-BET bromodomain inhibitor. It has a role as a BET bromodomain inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of pyridines, an aromatic ether, an imidazoquinoline and a member of isoxazoles.
Source: ChEBI
| Molecular formula | C23H21N5O3 |
|---|---|
| Molecular weight | 415.4 g/mol |
| IUPAC name | 7-(3,5-dimethyl-1,2-oxazol-4-yl)-8-methoxy-1-[(1R)-1-pyridin-2-ylethyl]-3H-imidazo[4,5-c]quinolin-2-one |
| InChIKey | VUVUVNZRUGEAHB-CYBMUJFWSA-N |
| SMILES | CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)[C@H](C)C5=CC=CC=N5)OC |
Computed by PubChem (NCBI)